Back to search
The HOPE (Heart Outcomes Prevention Evaluation) Study: The design of a large, simple randomized trial of an angiotensin converting enzyme inhibitor (ramipril) and vitamin E in patients at high risk of cardiovascular events
Data up to Jan 2025
Published1996
Citations154
References0
Total Citations Per Year
Abstract
References (0)
No references found
Cited By (0)
Loading...